RAPT Therapeutics, Inc.

NASDAQ:RAPT

3.1 (USD) • At close November 7, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017
Operating Activities:
Net Income -116.798-83.838-69.204-52.892-42.997-36.147-29.115
Depreciation & Amortization 3.5511.0470.9961.1231.331.2371.384
Deferred Income Tax -7.335000-0.0110.0170.015
Stock Based Compensation 17.09111.2649.9528.6862.0511.170.716
Change In Working Capital 5.499-1.335-4.2982.3444.1330.784-0.114
Accounts Receivables 0000000
Inventory 0000000
Accounts Payables 7.3353.710.9332.390.7361.475-0.08
Other Working Capital -1.836-5.045-5.231-0.0463.397-0.691-0.034
Other Non Cash Items 0.9442.0911.5280.2480.02-0.014-0.009
Operating Cash Flow -97.048-70.771-61.026-40.491-35.474-32.953-27.123
Investing Activities:
Investments In Property Plant And Equipment -1.125-0.845-0.755-0.398-0.888-3.5-1.124
Acquisitions Net -105.25844.64580.59287.0370.04500
Purchases Of Investments -161.497-190.856-164.977-139.334000
Sales Maturities Of Investments 266.755146.21184.38552.297000
Other Investing Activites 105.258-44.645-80.592-87.0370.04500
Investing Cash Flow 104.133-45.49-81.347-87.435-0.843-3.5-1.124
Financing Activities:
Debt Repayment 0000000
Common Stock Issued 1.447129.788139.4675.46149.9020.2660.246
Common Stock Repurchased 0000.8960.80200
Dividends Paid 0000000
Other Financing Activities 1.4471.3922.02275.46149.90252.46829.856
Financing Cash Flow 1.447131.18141.48275.46149.90252.73430.102
Other Information:
Effect Of Forex Changes On Cash 0000000
Net Change In Cash 8.53214.919-0.891-52.46513.58516.2811.855
Cash At End Of Period 47.47838.94624.02724.91877.38363.79847.517